| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 35.82▲ | 35.78▲ | 35.78▲ | 35.86▲ | 35.75▲ |
| MA10 | 35.79▲ | 35.77▲ | 35.77▲ | 35.85▲ | 35.68▲ |
| MA20 | 35.78▲ | 35.79▲ | 35.81▲ | 35.74▲ | 35.39▲ |
| MA50 | 35.79▲ | 35.73▲ | 35.71▲ | 35.64▲ | 34.31▲ |
| MA100 | 35.71▲ | 35.70▲ | 35.70▲ | 35.32▲ | 32.99▲ |
| MA200 | 35.71▲ | 35.60▲ | 35.51▲ | 34.54▲ | 32.26▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.000▼ | -0.003▼ | 0.003▲ | -0.024▼ |
| RSI | 63.135▲ | 58.393▲ | 57.369▲ | 55.580▲ | 74.920▲ |
| STOCH | 94.444▲ | 54.431 | 50.860 | 59.615 | 75.777 |
| WILL %R | 0.000▲ | 0.000▲ | -35.484 | -36.923 | -19.512▲ |
| CCI | 213.740▲ | 170.537▲ | 50.939 | 29.860 | 92.954 |
|
Monday, September 29, 2025 04:41 AM
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 35.72 | 35.90 | 35.68 | 35.90 | 59,874 |
| 29/09/25 | 35.80 | 35.8147 | 35.7205 | 35.77 | 22,431 |
| 26/09/25 | 35.79 | 35.85 | 35.78 | 35.85 | 17,404 |
| 25/09/25 | 35.79 | 36.00 | 35.49 | 35.79 | 110,878 |
| 24/09/25 | 35.95 | 36.01 | 35.9401 | 35.98 | 10,343 |
| 23/09/25 | 36.14 | 36.14 | 35.93 | 36.00 | 9,039 |
| 22/09/25 | 35.70 | 35.85 | 35.70 | 35.85 | 12,932 |
| 19/09/25 | 35.88 | 35.88 | 35.56 | 35.72 | 36,603 |
| 18/09/25 | 35.78 | 36.05 | 35.78 | 36.01 | 27,978 |
| 17/09/25 | 35.70 | 35.70 | 35.58 | 35.62 | 47,626 |
|
|
||||
|
|
||||
|
|